Mr. Spaight is an Operating Partner of Arsenal for the healthcare team. Prior to joining Arsenal in 2016, Mr. Spaight served as the Chairman and CEO of WIL Research Laboratories, a leading pre-clinical (“CRO”) acquired by Charles River Laboratories. Prior to WIL, he served as President of MDS Pharma Services, a global CRO serving all phases of pharmaceutical research and development, from early discovery to late-stage clinical trials and central laboratory support. Prior to MDS, he held senior leadership positions in Fisher Scientific Products and PerkinElmer.
- M.B.A., University of Michigan
- B.S., University of Michigan